In a study by Hu et al., miR-373-3p was found to reduce the expression of Cyclin D2, resulting in increased sensitivity to gemcitabine and the suppression of growth in gemcitabine-resistant pancreatic cancer cells [104]. The gene discussed is CCND2; the disease is pancreatic neoplasm.